novo nordisk weight loss

News

Novo Nordisk to sell weight-loss drug for $499

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

· 4h · on MSN

Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership

· 5h · on MSN

Wegovy News Pushes Novo Nordisk Stock Higher

7hon MSN

Eli Lilly, Novo Nordisk latest battle in GLP-1 market war: cash-paying customers

Eli Lilly & Novo Nordisk target cash-pay customers in the GLP-1 weight loss market with $499 monthly offers. Read more here.

16h

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Parkersburg News and Sentinel3mon

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results